Visit cvs.com … Do not give Clindamycin Phosphate Foam, 1% to other people, even if they have the same symptoms you have. This leaflet does not take the place of talking with your doctor about your medical condition or treatment.Clindamycin Phosphate Foam, 1% is a prescription medicine used on the skin (topical) to treat acne in people 12 years and older.It is not known if Clindamycin Phosphate Foam, 1% is safe and effective in children under 12 years of age.You and your doctor should decide if you will use Clindamycin Phosphate Foam, 1% or breastfeed. 320.22(b)(3), generic versions of Clindamycin Phosphate Topical Foam Aerosol, 1% must contain the same active ingredient in the same concentration and dosage form as the Reference Listed Drug (RLD) and must not have an inactive ingredient or other change in formulation from Do not expose to heat or store at temperature above 120°F (49°C).Patients should wash their hands after applying Clindamycin Phosphate Foam, 1%.Clindamycin Phosphate Foam, 1% may cause irritation such as erythema, scaling, itching, burning, or stinging. Clindamycin Topical foam 1pct Drug Medication Dosage information. There may be new information. For a rat, this dose is 84 fold higher, and for a mouse 42 fold higher, than the anticipated human dose of clindamycin phosphate from clindamycin phosphate foam, 1% based on a mg/mIt is not known whether clindamycin is excreted in human milk following use of Clindamycin Phosphate Foam, 1%. Tell your doctor about the allergy and what signs you had. The following information includes only the average doses of this medicine.

Keep from freezing.Do not keep outdated medicine or medicine no longer needed.Portions of this document last updated: May 01, 2020Copyright © 2020 IBM Watson Health. If you stop using this medicine too soon, your symptoms may return.

Do not puncture or incinerate.

Concomitant topical acne therapy should be used with caution since a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating, or abrasive agents. Intravenous form. The alcohol in it may irritate freshly washed or shaved skin. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Treatment response, defined as the proportion of subjects clear or almost clear, based on the Investigator Static Global Assessment (ISGA), and the mean percent reductions in lesion counts at the end of treatment in this study are shown in Table 2.Clindamycin Phosphate Foam, 1% containing clindamycin phosphate equivalent to 10 mg clindamycin per gram, is white to off-white in color and thermolabile.Store at 20-25°C (68-77°F) [see USP controlled room temperature].Flammable.

No significant increase in tumors was noted in the treated animals.A 1.2% clindamycin phosphate gel similar to Clindamycin Phosphate Foam, 1% caused a statistically significant shortening of the median time to tumor onset in a study in hairless mice in which tumors were induced by exposure to simulated sunlight.Genotoxicity tests performed included a rat micronucleus test and an Ames Salmonella reversion test.

Clindamycin has been shown to have The treatment of acne with antimicrobials is associated with the development of antimicrobial resistance in Resistance to clindamycin is often associated with resistance to erythromycin.The carcinogenicity of a 1.2% clindamycin phosphate gel similar to Clindamycin Phosphate Foam, 1% was evaluated by daily application to mice for two years. Clindamycin is an antibiotic used for treating serious infections. What is clindamycin phosphate-vaginal cream, and how does it work (mechanism of action)? André Bryskier, in Infectious Diseases (Third Edition), 2010. Visit cvs.com for more details.

All rights reserved. Antiperistaltic agents such as opiates and diphenoxylate with atropine may prolong and/or worsen severe colitis. However, to help keep your acne under control, keep using this medicine for the full time of treatment, even if your symptoms begin to clear up after a few days. Orally and parenterally administered clindamycin have been associated with severe colitis, which may end fatally.Clindamycin Phosphate Foam, 1% should not be used in combination with topical or oral erythromycin-containing products due to possible antagonism to its clindamycin component. Do not use near heat, near open flame, or while smoking. You may report side effects to Perrigo at 1-866-634-9120.Medicines are sometimes prescribed for purposes other than those listed in Patient Information. You may have to continue using this medicine every day for months or even longer in some cases. If contact occurs, rinse thoroughly with water.Clindamycin Phosphate Foam, 1% should be prescribed with caution in atopic individuals.Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.A total of 439 subjects with mild to moderate acne vulgaris were treated once daily for 12 weeks with clindamycin phosphate foam, 1%.In a contact sensitization study, none of the 203 subjects developed evidence of allergic contact sensitization to clindamycin phosphate foam, 1%.The following adverse reactions have been identified during post approval use of clindamycin phosphate foam, 1%: application site pain, application site erythema, diarrhea, urticaria, abdominal pain, hypersensitivity, rash, abdominal discomfort, nausea, seborrhea, application site rash, dizziness, pain of skin, colitis (including pseudomembranous colitis), and hemorrhagic diarrhea. This medicine contains alcohol and is flammable.

Do not use Clindamycin Phosphate Foam, 1% in your eyes, mouth or vagina.What should I tell my doctor before using Clindamycin Phosphate Foam, 1%? It is effective against several types of bacteria such as Staphylococcus aureus , Streptococcus pneumoniae , and Staphylococcus epidermidis , and Propionibacterium acnes . Therefore, Clindamycin Phosphate Foam, 1% should be used with caution in patients receiving such agents.Pregnancy Category B: There are no adequate and well-controlled studies in pregnant women treated with clindamycin phosphate foam, 1%. Clindamycin Topical foam drug summary. © 1998-2020 Mayo Foundation for Medical Education and Research (MFMER).